Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 5
2015 7
2016 5
2017 6
2018 8
2019 5
2020 5
2021 2
2022 2
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators. Thatcher N, et al. Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1. Lancet Oncol. 2015. PMID: 26045340 Free article. Clinical Trial.
[Lung cancer in HIV-infected patients].
Domblides C, Canellas A, Wislez M, Fallet V, Antoine M, Crequit P, Cadranel J, Lavolé A. Domblides C, et al. Among authors: crequit p. Bull Cancer. 2018 Jan;105(1):111-119. doi: 10.1016/j.bulcan.2017.11.002. Epub 2017 Dec 22. Bull Cancer. 2018. PMID: 29269175 Review. French.
[Management of malignant pericardial effusion in lung cancer].
Rousseau-Bussac G, Crequit P, Alifano M, Chouaid C. Rousseau-Bussac G, et al. Among authors: crequit p. Rev Mal Respir. 2014 Oct;31(8):746-53. doi: 10.1016/j.rmr.2014.02.011. Epub 2014 Apr 24. Rev Mal Respir. 2014. PMID: 25391509 Review. French.
[Supportive cares on thoracic oncology].
Rousseau-Bussac G, Crequit P, Masanes MJ, Chouaïd C. Rousseau-Bussac G, et al. Among authors: crequit p. Bull Cancer. 2012 Nov;99(11):1057-64. doi: 10.1684/bdc.2012.1650. Bull Cancer. 2012. PMID: 23073345 Review. French.
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study.
Pons-Tostivint E, Ezzedine R, Goronflot T, Crequit P, Chatellier T, Raimbourg J, Bennouna J, Giroux Leprieur E, Porte M. Pons-Tostivint E, et al. Among authors: crequit p. Lung Cancer. 2024 Aug;194:107887. doi: 10.1016/j.lungcan.2024.107887. Epub 2024 Jul 8. Lung Cancer. 2024. PMID: 38991282 Free article.
A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients.
Porte M, Vaudron A, Crequit P, Vaugier L, Chatellier T, Fronteau C, Raimbourg J, Goronflot T, Bennouna J, Pons-Tostivint E. Porte M, et al. Among authors: crequit p. Clin Lung Cancer. 2024 Mar;25(2):e101-e111.e2. doi: 10.1016/j.cllc.2023.11.009. Epub 2023 Nov 23. Clin Lung Cancer. 2024. PMID: 38072729
Mapping of Crowdsourcing in Health: Systematic Review.
Créquit P, Mansouri G, Benchoufi M, Vivot A, Ravaud P. Créquit P, et al. J Med Internet Res. 2018 May 15;20(5):e187. doi: 10.2196/jmir.9330. J Med Internet Res. 2018. PMID: 29764795 Free PMC article.
40 results